Janssen Announces U.S. FDA Approval of SYMTUZA ™ (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | Prezista